cervical carcinoma: A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.
Other benign neoplasm of uterus: Cervix uteri
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_CERVIX_UTERI
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
214 |
4. Check minimum number of eventsNone |
214 |
5. Include endpointsNone |
214 |
6. Filter based on genotype QC (FinnGen only) |
214 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D26
- Name in latin
- Neoplasma benignum cervicis uteri
Similar endpoints
↥List of similar endpoints to
Other benign neoplasm of uterus: Cervix uteri
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasm of uterus: Cervix uteri
- Other benign neoplasms of uterus
- Other benign neoplasms of uterus
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1668 | 1668 | - |
| Only index persons | 1538 | 1538 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | - |
| Only index persons | 0.06 | 0.06 | - |
| Median age at first event (years) | |||
| Whole population | - | 47.87 | - |
| Only index persons | - | 47.37 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 214 | 214 | - |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | - |
| Median age at first event (years) | 47.37 | 47.37 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 185
- Matched controls
- 1850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D26.0
ICD-10 Finland
Other benign neoplasm: Cervix uteri
+∞
171.7
137
*
2190A
ICD-9 Finland
Other benign neoplasm of uterus, Cervix uteri
+∞
51.5
47
*
LDB00
NOMESCO Finland
Excision of lesion of cervix uteri
15.7
16.1
26
19
N84.1
ICD-10 Finland
Polyp of cervix uteri
8.9
11.8
25
32
8113
FHL
Fractional scraping
4.0
8.7
36
106
8111
FHL
Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)
41.6
6.8
8
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.7
6.1
44
192
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
36
177
2.24
4.26
2.6
3.2
19.3
35.7
u/ml
1.10
36
170
23
92
2.68
4.21
1.4
1.5
—
—
—
0
0
24
104
2.47
3.75
1.5
1.6
—
—
—
0
0
26
130
2.14
2.96
1.9
1.8
—
—
—
0
0
5
7
7.28
2.56
1.8
2.9
—
—
—
0
0
68
499
1.53
2.13
1.4
1.4
—
—
—
0
0
12
52
2.39
1.91
1.5
1.3
—
—
—
0
0
161
1429
1.51
1.84
7.4
7.1
80.6
76.5
u/l
0.27
150
1328
5
13
3.91
1.72
1.2
1.9
—
—
—
0
0
50
361
1.50
1.66
1.8
1.6
512195564.6
17123752.2
pmol/l
0.69
41
292
12
57
2.17
1.58
1.3
1.3
—
—
—
0
0
6
21
2.91
1.51
1.2
1.7
—
—
—
0
0
193
1806
1.70
1.51
4.8
4.3
5.8
5.8
mmol/l
0.09
180
1657
5
16
3.17
1.44
1.2
1.8
—
—
—
0
0
70
564
1.36
1.26
2.4
2.2
52.9
56.4
u/l
0.64
65
521
37
266
1.47
1.26
2.6
2.7
5.1
4.0
e6/l
0.18
20
135
6
25
2.44
1.25
2.8
1.3
—
—
—
0
0
170
1566
1.42
1.24
4.8
4.4
14.7
14.6
pmol/l
0.09
158
1442
12
64
1.93
1.20
1.3
1.5
288.8
281.8
mu/l
0.05
12
58
8
39
2.09
1.16
1.1
1.6
—
—
—
0
0
80
668
1.32
1.12
3.7
3.1
2.4
2.4
mmol/l
0.31
68
589
181
1701
1.42
1.04
6.3
5.2
39.1
38.8
mmol/mol
0.15
167
1583
113
1258
0.78
0.98
4.1
3.3
—
—
—
0
0
55
444
1.32
0.96
1.7
1.7
1.0
0.9
mg/l
0.14
43
342
10
55
1.86
0.93
1.3
1.1
—
—
—
0
0
9
52
1.76
0.93
1.4
2.0
—
—
—
0
0
39
302
1.36
0.90
1.6
1.7
1286.2
1221.1
nmol/l
0.14
30
215
23
162
1.47
0.89
2.7
5.1
282.3
254.6
u/l
0.22
23
153
179
1692
1.35
0.87
16.4
13.3
38.4
39.5
%
0.78
127
1259
6
31
1.96
0.85
1.5
1.0
—
—
—
0
0
14
89
1.61
0.83
1.7
1.4
—
—
—
0
0
111
994
1.24
0.83
5.4
5.6
9.3
9.7
umol/l
0.25
106
934
25
182
1.42
0.82
2.1
4.0
5.1
7.7
ug/l
0.30
19
148
23
165
1.44
0.82
2.0
1.8
—
—
—
0
0
20
140
1.47
0.80
1.2
1.3
28.1
28.9
iu/l
0.04
20
122
30
227
1.37
0.80
1.4
1.9
—
—
—
0
0
195
1874
1.46
0.80
4.7
4.7
2.9
2.9
mmol/l
0.02
180
1729
134
1228
1.24
0.80
3.4
2.8
45.9
39.6
u/l
0.36
123
1147
6
33
1.84
0.79
4.7
3.1
11.7
63.1
u/ml
—
6
33
105
938
1.23
0.79
4.2
3.6
0.0
0.0
estimate
0.00
17
174
196
1887
1.46
0.77
15.0
13.4
139.7
139.7
mmol/l
0.05
189
1832
23
167
1.42
0.77
2.0
1.8
—
—
—
0
0
20
142
1.45
0.75
3.1
2.7
1.1
2.2
mmol/l
1.06
13
116
106
952
1.22
0.75
4.2
3.7
0.2
0.0
estimate
0.48
19
170
105
944
1.22
0.73
6.5
5.0
0.0
0.0
estimate
0.00
17
177
12
77
1.59
0.70
3.3
2.4
24.5
25.1
mmol/l
0.39
12
77
5
27
1.87
0.69
1.2
1.3
—
—
—
0
0
5
28
1.80
0.66
1.2
2.3
—
—
—
0
0
112
1020
1.21
0.66
4.2
3.9
6.5
6.5
mmol/l
0.01
101
939
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
16
115
1.42
0.58
1.9
1.6
—
—
—
0
0
6
35
1.73
0.58
1.3
1.6
—
—
—
0
0
195
1890
1.36
0.58
15.1
13.5
4.0
3.9
mmol/l
0.60
188
1831
5
86
0.57
0.57
1.0
2.6
29.4
41.6
u/l
—
5
78
6
36
1.69
0.57
1.3
1.6
—
—
—
0
0
36
431
0.80
0.55
1.7
1.5
21.5
22.9
nmol/l
0.24
30
359
6
39
1.55
0.53
1.5
1.3
—
—
—
0
0
26
207
1.29
0.52
1.5
1.8
—
—
—
0
0
31
253
1.26
0.52
2.0
1.9
—
—
—
0
0
11
75
1.49
0.52
4.2
2.9
52.5
46.2
%
0.29
11
75
201
1962
1.40
0.51
11.1
10.1
24.1
23.6
u/l
0.20
192
1890
117
1087
1.17
0.51
8.0
8.8
3.8
3.9
e9/l
0.25
103
964
68
606
1.18
0.49
2.9
2.8
—
—
—
0
0
27
220
1.26
0.46
4.9
5.3
—
—
—
0
0
98
903
1.16
0.46
3.3
2.8
85.2
78.2
ug/l
0.28
92
842
21
166
1.29
0.45
5.4
5.5
1.6
1.5
mmol/l
0.01
16
133
8
59
1.37
0.41
2.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
1.2
—
0
9
50
442
1.17
0.40
3.0
2.0
2.8
3.3
mg/l
0.81
42
373
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
47
414
1.17
0.39
2.2
1.5
—
—
—
0
0
34
292
1.20
0.37
2.6
2.5
1.9
1.1
e6/l
0.45
18
159
10
72
1.41
0.37
1.3
1.7
—
—
—
0
0
188
1832
1.22
0.37
4.3
4.2
1.6
1.6
mmol/l
0.15
178
1689
189
1844
1.21
0.35
4.4
4.2
4.8
4.9
mmol/l
0.13
180
1709
180
1751
1.18
0.34
3.8
3.8
1.2
1.2
mmol/l
0.22
166
1608
98
920
1.12
0.32
6.4
5.5
1.2
1.2
mmol/l
1.15
83
776
7
100
0.69
0.31
2.0
1.5
—
—
—
0
0
90
844
1.11
0.30
4.9
4.8
1.2
1.2
mmol/l
0.11
77
764
26
224
1.18
0.29
4.7
4.1
34.2
34.5
%
0.04
15
138
9
118
0.75
0.28
1.9
1.3
—
—
—
0
0
83
882
0.90
0.27
4.7
3.8
—
—
—
0
0
79
741
1.10
0.26
4.3
3.6
—
—
—
0
0
14
169
0.82
0.25
1.0
1.2
244.2
177.6
iu/ml
—
7
77
44
401
1.12
0.24
1.4
1.3
1.0
9.6
u/ml
2.71
19
157
39
429
0.89
0.23
1.9
2.2
—
—
—
0
0
180
1764
1.13
0.22
10.4
11.6
82.0
82.6
ml/min/173m2
0.15
136
1425
5
41
1.22
0.22
2.4
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
3.9
—
482.4
—
0
10
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
5
43
1.17
0.21
1.2
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
49
1.23
0.20
2.2
1.1
—
—
—
0
0
36
328
1.12
0.20
3.6
3.5
239.6
153.8
ng/l
0.18
23
230
5
70
0.71
0.17
1.6
1.1
—
—
—
0
0
5
70
0.71
0.17
1.6
1.1
—
—
—
0
0
8
70
1.15
0.16
1.9
2.0
—
—
—
0
0
10
83
1.21
0.15
1.9
2.0
1.1
1.1
%
—
10
83
57
542
1.07
0.13
2.3
2.0
108.5
137.6
u/l
0.86
49
509
183
1811
1.07
0.09
5.8
5.2
1.9
2.5
mu/l
0.39
169
1675
76
737
1.05
0.09
1.9
1.9
112.9
99.8
pmol/l
1.06
38
337
7
85
0.82
0.07
7.9
4.1
24.5
25.2
mmol/l
—
7
85
9
87
1.04
0.07
7.0
6.2
1.6
1.4
%
—
9
87
9
103
0.87
0.06
1.2
1.4
—
—
—
0
0
66
643
1.04
0.06
2.9
3.4
197.7
25.8
ng/l
0.48
37
420
51
494
1.04
0.06
1.3
1.3
0.5
2.2
u/ml
1.11
17
139
41
395
1.05
0.06
1.3
1.3
16.1
36.8
iu/ml
1.89
12
139
13
121
1.08
0.04
2.8
2.4
117.5
150.2
ng/l
0.28
13
108
17
161
1.06
0.03
2.1
3.3
—
—
—
0
0
47
479
0.98
0.02
3.1
2.8
0.4
0.5
e6/l
0.05
29
347
53
522
1.02
0.01
1.6
1.6
1.5
1.3
mmol/l
0.60
48
440
12
114
1.06
0.01
1.0
1.0
—
—
—
0
0
46
466
0.98
0.00
2.3
3.0
620.4
811.7
ng/l
0.59
39
394
50
506
0.98
0.00
3.5
3.9
0.0
0.0
estimate
0.00
19
178
19
186
1.02
0.00
4.6
4.7
106.3
103.7
mmol/l
1.79
19
181
23
226
1.02
0.00
3.7
2.2
20.0
22.1
%
0.34
18
189
86
861
1.00
0.00
2.3
2.2
79.9
78.9
nmol/l
0.10
80
768
19
187
1.02
0.00
1.5
1.6
—
—
—
0
0
144
1437
1.01
0.00
4.8
4.1
12.2
11.2
mm/h
0.50
132
1319
187
1868
1.01
0.00
15.6
12.3
20.2
19.6
mg/l
0.11
147
1425
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
59
0.84
0.00
2.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
11.6
—
0
9
6
67
0.89
0.00
1.5
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
9
90
1.00
0.00
2.4
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
1415.1
—
0
8
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
71.2
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CERVIX_UTERI and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CERVIX_UTERI | 1.246 [0.97, 1.6] | 0.081 |
| Birth year | 0.996 [0.99, 1.0] | 0.33 |
During the follow-up period (1.1.1998 — 31.12.2019), 75 out of 822 females with CD2_BENIGN_CERVIX_UTERI died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CERVIX_UTERI.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.128% | No data |
| 5 | 0.776% | No data |
| 10 | 2.011% | No data |
| 15 | 3.774% | No data |
| 20 | 6.605% | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CERVIX_UTERI – Other benign neoplasm of uterus: Cervix uteri
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data